LAKE STREET ADVISORS GROUP, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
LAKE STREET ADVISORS GROUP, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$18,000
-10.0%
17,0000.0%0.00%0.0%
Q1 2022$20,000
+81.8%
17,000
+70.0%
0.00%0.0%
Q4 2021$11,000
-8.3%
10,0000.0%0.00%0.0%
Q3 2021$12,00010,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CAMDEN ASSET MANAGEMENT L P /CA 37,725,000$44,872,0001.86%
SHENKMAN CAPITAL MANAGEMENT INC 4,839,000$5,831,0000.53%
AQR Arbitrage LLC 13,500,000$16,193,0000.46%
Context Capital Management, LLC 3,934$4,719,0000.44%
Polar Asset Management Partners Inc. 7,000,000$8,387,0000.09%
Calamos Advisors LLC 9,500,000$11,397,0000.05%
LINDEN ADVISORS LP 6,998,000$8,394,0000.04%
LAZARD ASSET MANAGEMENT LLC 16,318,000$19,572,0000.02%
Citadel Advisors 68,788,000$82,290,0000.02%
PUTNAM INVESTMENTS LLC 7,564,000$8,997,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders